[1]
Halboos, N.A. and Alasady, R.A. 2025. Assessment of Serum Interleukin-23 as a Biomarker for Diagnosis and Disease Activity Evaluation in Ankylosing Spondylitis Patients. Al-Kufa University Journal for Biology. 17, 2 (Aug. 2025), 138–147. DOI:https://doi.org/10.36320/ajb/v17.i2.20076.